27398974|t|Hyaluronan Depolymerization by Megakaryocyte Hyaluronidase-2 Is Required for Thrombopoiesis
27398974|a|Hyaluronan is the predominant glycosaminoglycan component of the extracellular matrix with an emerging role in hematopoiesis. Modulation of hyaluronan polymer size is responsible for its control over cellular functions, and the balance of hyaluronan synthesis and degradation determines its molecular size. Although two active somatic hyaluronidases are expressed in mammals, only deficiency in hyaluronidase-2 (Hyal-2) results in thrombocytopenia of unknown mechanism. Our results reveal that Hyal-2 knockout mice accumulate hyaluronan within their bone marrow and within megakaryocytes, the cells responsible for platelet generation. Proplatelet formation by Hyal-2 knockout megakaryocytes was disrupted because of abnormal formation of the demarcation membrane system, which was dilated and poorly developed. Importantly, peptide-mediated delivery of exogenous hyaluronidase rescued deficient proplatelet formation in murine and human megakaryocytes lacking Hyal-2. Together, our data uncover a previously unsuspected mechanism of how hyaluronan and Hyal-2 control platelet generation.
27398974	0	10	Hyaluronan	T109,T121,T123	C0813622
27398974	11	27	Depolymerization	T044	C1523275
27398974	31	44	Megakaryocyte	T025	C0025166
27398974	45	60	Hyaluronidase-2	T116,T126	C1172589
27398974	77	91	Thrombopoiesis	T043	C0221145
27398974	92	102	Hyaluronan	T109,T121,T123	C0813622
27398974	122	149	glycosaminoglycan component	T109,T121,T123	C0017973
27398974	157	177	extracellular matrix	T024	C0015350
27398974	203	216	hematopoiesis	T042	C0018951
27398974	218	228	Modulation	UnknownType	C0678672
27398974	232	242	hyaluronan	T109,T121,T123	C0813622
27398974	243	255	polymer size	T081	C0596969
27398974	292	310	cellular functions	T043	C0007613
27398974	331	341	hyaluronan	T109,T121,T123	C0813622
27398974	342	351	synthesis	T038	C0220781
27398974	356	367	degradation	T040	C0699900
27398974	383	397	molecular size	T081	C0596969
27398974	419	426	somatic	T080	C2986476
27398974	427	441	hyaluronidases	T116,T121,T126	C0020197
27398974	446	455	expressed	T045	C1171362
27398974	459	466	mammals	T015	C0024660
27398974	487	502	hyaluronidase-2	T116,T126	C1172589
27398974	504	510	Hyal-2	T116,T126	C1172589
27398974	523	539	thrombocytopenia	T047	C0040034
27398974	586	592	Hyal-2	T028	C1415826
27398974	593	606	knockout mice	T015	C0206745
27398974	618	628	hyaluronan	T109,T121,T123	C0813622
27398974	642	653	bone marrow	T024	C0005953
27398974	665	679	megakaryocytes	T025	C0025166
27398974	685	690	cells	T025	C0007634
27398974	707	726	platelet generation	T043	C0221145
27398974	728	749	Proplatelet formation	T043	C0221145
27398974	753	759	Hyal-2	T028	C1415826
27398974	760	768	knockout	T050	C1522225
27398974	769	783	megakaryocytes	T025	C0025166
27398974	788	797	disrupted	T080	C0332454
27398974	809	817	abnormal	T033	C0205161
27398974	818	827	formation	T169	C1522492
27398974	835	862	demarcation membrane system	T026	C3161472
27398974	917	942	peptide-mediated delivery	T061	C0565867
27398974	946	955	exogenous	T082	C0205101
27398974	956	969	hyaluronidase	T116,T121,T126	C0020197
27398974	988	1009	proplatelet formation	T043	C0221145
27398974	1013	1019	murine	T015	C0026809
27398974	1024	1029	human	T016	C0086418
27398974	1030	1044	megakaryocytes	T025	C0025166
27398974	1053	1059	Hyal-2	T116,T126	C1172589
27398974	1075	1079	data	T078	C1511726
27398974	1130	1140	hyaluronan	T109,T121,T123	C0813622
27398974	1145	1151	Hyal-2	T116,T126	C1172589
27398974	1160	1179	platelet generation	T043	C0221145